Cargando…
Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk
PURPOSE/OBJECTIVE: To evaluate the potential of stereotactic magnetic resonance-guided online adaptive radiotherapy (SMART) to fulfill dose recommendations for stereotactic body radiotherapy (SBRT) of adrenal metastases and spare organs at risk (OAR). MATERIALS AND METHODS: In this subgroup analysis...
Autores principales: | Hoegen, Philipp, Katsigiannopulos, Efthimios, Buchele, Carolin, Regnery, Sebastian, Weykamp, Fabian, Sandrini, Elisabetta, Ristau, Jonas, Liermann, Jakob, Meixner, Eva, Forster, Tobias, Renkamp, C. Katharina, Schlüter, Fabian, Rippke, Carolin, Debus, Jürgen, Klüter, Sebastian, Hörner-Rieber, Juliane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014324/ https://www.ncbi.nlm.nih.gov/pubmed/36935853 http://dx.doi.org/10.1016/j.ctro.2022.100567 |
Ejemplares similares
-
Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2023) -
Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2022) -
Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes
por: Weykamp, Fabian, et al.
Publicado: (2021) -
Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes
por: Weykamp, Fabian, et al.
Publicado: (2021) -
Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)
por: Regnery, Sebastian, et al.
Publicado: (2022)